CA2489282A1 - Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques - Google Patents

Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques Download PDF

Info

Publication number
CA2489282A1
CA2489282A1 CA002489282A CA2489282A CA2489282A1 CA 2489282 A1 CA2489282 A1 CA 2489282A1 CA 002489282 A CA002489282 A CA 002489282A CA 2489282 A CA2489282 A CA 2489282A CA 2489282 A1 CA2489282 A1 CA 2489282A1
Authority
CA
Canada
Prior art keywords
vip
vasodilator
restenosis
blood flow
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002489282A
Other languages
English (en)
Inventor
Leo Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2489282A1 publication Critical patent/CA2489282A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2271—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
CA002489282A 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques Abandoned CA2489282A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16605902A 2002-06-10 2002-06-10
US10/166,059 2002-06-10
PCT/US2003/018059 WO2003103743A2 (fr) 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques

Publications (1)

Publication Number Publication Date
CA2489282A1 true CA2489282A1 (fr) 2003-12-18

Family

ID=29732103

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002489282A Abandoned CA2489282A1 (fr) 2002-06-10 2003-06-10 Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques

Country Status (5)

Country Link
EP (1) EP1551334A4 (fr)
JP (1) JP2005528956A (fr)
AU (1) AU2003243439A1 (fr)
CA (1) CA2489282A1 (fr)
WO (1) WO2003103743A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399480B2 (en) 1997-09-26 2008-07-15 Abbott Laboratories Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
US8500795B2 (en) 1999-08-09 2013-08-06 Cardiokinetix, Inc. Retrievable devices for improving cardiac function
US8388672B2 (en) 1999-08-09 2013-03-05 Cardiokinetix, Inc. System for improving cardiac function by sealing a partitioning membrane within a ventricle
US7674222B2 (en) 1999-08-09 2010-03-09 Cardiokinetix, Inc. Cardiac device and methods of use thereof
US10307147B2 (en) 1999-08-09 2019-06-04 Edwards Lifesciences Corporation System for improving cardiac function by sealing a partitioning membrane within a ventricle
US9694121B2 (en) 1999-08-09 2017-07-04 Cardiokinetix, Inc. Systems and methods for improving cardiac function
US8257428B2 (en) 1999-08-09 2012-09-04 Cardiokinetix, Inc. System for improving cardiac function
US8529430B2 (en) 2002-08-01 2013-09-10 Cardiokinetix, Inc. Therapeutic methods and devices following myocardial infarction
US9078660B2 (en) 2000-08-09 2015-07-14 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
US9332992B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Method for making a laminar ventricular partitioning device
US10064696B2 (en) 2000-08-09 2018-09-04 Edwards Lifesciences Corporation Devices and methods for delivering an endocardial device
US9332993B2 (en) 2004-08-05 2016-05-10 Cardiokinetix, Inc. Devices and methods for delivering an endocardial device
WO2007130724A2 (fr) 2006-02-06 2007-11-15 Northwind Ventures Systèmes et procédés de réduction de volume
US8404281B2 (en) 2009-06-08 2013-03-26 Avant Garde Therapeutics & Technologies Llc Formulations
JP5875986B2 (ja) 2009-10-26 2016-03-02 カーディオキネティックス・インコーポレイテッドＣａｒｄｉｏｋｉｎｅｔｉｘ， Ｉｎｃ． 心室容積縮小
US20140328933A1 (en) * 2010-06-16 2014-11-06 Shaker Mousa Novel formulations and methods
WO2013090848A1 (fr) * 2011-12-15 2013-06-20 The Board Of Trustees Of The Leland Stanford Junior University Appareil et procédés de traitement de l'hypertension pulmonaire
US10751183B2 (en) 2014-09-28 2020-08-25 Edwards Lifesciences Corporation Apparatuses for treating cardiac dysfunction
DE102018107407A1 (de) 2017-03-28 2018-10-04 Edwards Lifesciences Corporation Positionieren, einsetzen und zurückholen von implantierbaren vorrichtungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5603722A (en) * 1995-06-06 1997-02-18 Quanam Medical Corporation Intravascular stent
DE60117777T2 (de) * 2000-05-11 2006-08-17 Eastman Chemical Co., Kingsport Acylierte zyclodextrin guest-inklusion komplexe
US6613753B2 (en) * 2001-02-21 2003-09-02 Supergen, Inc. Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
US20030134811A1 (en) * 2001-10-09 2003-07-17 John Jackson Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents

Also Published As

Publication number Publication date
AU2003243439A8 (en) 2003-12-22
WO2003103743A3 (fr) 2004-07-22
JP2005528956A (ja) 2005-09-29
EP1551334A2 (fr) 2005-07-13
WO2003103743A2 (fr) 2003-12-18
AU2003243439A1 (en) 2003-12-22
EP1551334A4 (fr) 2006-12-13

Similar Documents

Publication Publication Date Title
US9216239B2 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
CA2489282A1 (fr) Dispositif medical permettant l'apport intraluminal d'agents pharmaceutiques
JP5153340B2 (ja) 薬剤放出制御組成物および薬剤放出性医療器具
JP6309988B2 (ja) 薬剤を分散させるための医療器具
DE602004004331T2 (de) Implantierbare Pumpe zur Behandlung von Fettleibigkeit
ES2223774T3 (es) Dispositivo medico.
US8187223B2 (en) Anti-restenosis drug covered and eluting balloons for valvuloplasty of aortic valve stenosis for the prevention of restenosis
US20070020306A1 (en) Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative
US20080161908A1 (en) Apparatus and Method for Delivery of Mitomycin Through an Eluting Biocompatible Implantable Medical Device
TW200306826A (en) Drug delivery systems for the prevention and treatment of vascular diseases
EP2111818B1 (fr) Stent intracoronaire comportant un revêtement à libération asymétrique régulée d'un médicament
JP2003501151A (ja) 動脈再狭窄治療用装置および化合物
EP2309979A1 (fr) Administration de formulations sèches d'octréotide
JP2006519623A (ja) タンパクチロシンキナーゼインヒビターで被覆されたまたは含浸された血管ステントまたは血管グラフト、およびその使用方法
MX2011000036A (es) Implante de octreotida que tiene un agente de liberacion.
JP2008529667A (ja) 医療デバイス
US20060088571A1 (en) Biocompatible and hemocompatible polymer compositions
US20080085293A1 (en) Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor
CN101378775A (zh) 对人促生长素抑制素受体亚型具有不同选择性的促生长素抑制素类似物的组合
CN101309706A (zh) 药剂释放控制组合物及药剂释放性医疗器具
US8357653B2 (en) System and method for inhibiting cellular proliferation with tachykinins
WO2001070295A1 (fr) Stent coronarien enduit d'un antagoniste de recepteur d'endotheline
US20050273177A1 (en) Prosthetic device having drug delivery properties
Jansen et al. Intravenously administered human Epidermal growth factor in the rat: Biliary excretion and influences on pancreatic secretion
DE102011012224A1 (de) Medizinisches Produkt zur Anwendung an Blutgefäßen

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued